Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid | Zendy

Joost M. Meijer | Zendy; Gilles F.H. Diercks | Zendy; Emma W. G. de Lang | Zendy; Hendri H. Pas | Zendy; Marcel F. Jonkman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid

Author(s) -

Joost M. Meijer,

Gilles F.H. Diercks,

Emma W. G. de Lang,

Hendri H. Pas,

Marcel F. Jonkman

Publication year - 2019

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2018.4390

Subject(s) - medicine , bullous pemphigoid , iif , pemphigoid , dermatology , hydroxychloroquine , medical diagnosis , biopsy , direct fluorescent antibody , indirect immunofluorescence , pathology , covid-19 , disease , immunology , infectious disease (medical specialty) , antibody , antigen

A substantial number of patients with bullous pemphigoid do not develop skin blisters and may not have received the correct diagnosis. Diagnostic criteria and an optimal diagnostic strategy are needed for early recognition and trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research